Nipah (NiV) and Hendra (HeV) viruses are highly pathogenic type species of the Henipavirus (HNV) genus within the Paramyxovirinae. Zoonotic transmission of NiV and HeV from their natural fruit bat reservoirs to humans can result in mortality rates in excess of 90%. Originally thought to be limited to Southeast Asia and Australia, the recent discovery of numerous divergent clades of HNVs across Africa, and of Henipa-like viruses (HNLV) in China such as the Mojiang paramyxovirus (MojPV), qualitatively changes the risk- calculus associated with the possible global emergence of these zoonotic viruses. Indeed, we recently found evidence for HNV spillover into human populations at high-risk for zoonotic transmission in Cameroon, which raise urgent questions about potential spillover events that may have remained undetected or misdiagnosed. The recent Ebola epidemic in West Africa underscores the importance of understanding the mechanisms of zoonotic spillover and transmission of highly pathogenic emerging viruses. HNVs use EphrinB2 and EphrinB3, highly conserved cellular proteins, as viral entry receptors. The recent discovery of novel HNVs with differential usage of EphrinB2 and B3 provides new opportunities to study how receptor usage contributes to the pathogenicity and potential for zoonotic spillover of these emergent HNVs. Our overall goal is to elucidate the envelope-receptor interactions of HNVs and HNLVs that contribute to viral tropism, pathogenicity, transmissibility, and the potential for zoonotic spillover. Our primary objective is to understand the structure-function correlates of envelope- receptor interactions in the pathobiology of HNV/HNLV zoonotic infections. A secondary objective is to leverage that understanding to interrogate the rational basis for a vaccine design that might elicit antibodies that are more broadly neutralizing and effective against an ever-expanding spectrum of diverse HNVs. Our driving hypothesis is: the structural plasticity of HNV-Gs accounts for the differential efficiency and choice of receptor usage exhibited by divergent HNVs, and that this contributes to a virulence spectrum among these zoonotic viruses that is equally diverse. To achieve our objectives and interrogate our driving hypothesis, we propose the following Specific Aims: (1) Investigate the role of receptor usage and choice in virus pathogenicity. (2) Evaluate how attachment protein-receptor interactions contribute to transmissibility and the potential for zoonotic spillover. (3) Examine the implications of the structural and phylogenetic diversity of HNVs on vaccine design.

Public Health Relevance

Henipaviruses (HNVs) are emerging paramyxoviruses that are classified as BSL4 select agents due to their extreme pathogenicity. They are zoonotic viruses that can cause severe disease in humans and livestock when spillover occurs from the natural animal reservoirs. We seek to understand the viral envelopereceptor interactions that contribute to viral pathogenicity and the potential for zoonotic spillover.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI123449-03
Application #
9532054
Study Section
Virology - B Study Section (VIRB)
Program Officer
Park, Eun-Chung
Project Start
2016-09-26
Project End
2021-08-31
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Lee, Benhur (2018) The quest for good explanations. PLoS Pathog 14:e1006818
Escaffre, Olivier; Hill, Terence; Ikegami, Tetsuro et al. (2018) Experimental Infection of Syrian Hamsters With Aerosolized Nipah Virus. J Infect Dis 218:1602-1610
Rima, Bert; Collins, Peter; Easton, Andrew et al. (2018) Problems of classification in the family Paramyxoviridae. Arch Virol 163:1395-1404
Dawes, Brian E; Kalveram, Birte; Ikegami, Tetsuro et al. (2018) Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Sci Rep 8:7604
Beaty, Shannon M; Park, Arnold; Won, Sohui T et al. (2017) Efficient and RobustParamyxoviridaeReverse Genetics Systems. mSphere 2:
Beaty, Shannon M; Nachbagauer, Raffael; Hirsh, Ariana et al. (2017) Cross-Reactive and Cross-Neutralizing Activity of Human Mumps Antibodies Against a Novel Mumps Virus From Bats. J Infect Dis 215:209-213
Amarasinghe, Gaya K; Bào, Y?míng; Basler, Christopher F et al. (2017) Taxonomy of the order Mononegavirales: update 2017. Arch Virol 162:2493-2504
Thibault, Patricia A; Watkinson, Ruth E; Moreira-Soto, Andres et al. (2017) Zoonotic Potential of Emerging Paramyxoviruses: Knowns and Unknowns. Adv Virus Res 98:1-55
Rissanen, Ilona; Ahmed, Asim A; Azarm, Kristopher et al. (2017) Idiosyncratic Mòji?ng virus attachment glycoprotein directs a host-cell entry pathway distinct from genetically related henipaviruses. Nat Commun 8:16060